# Computational simulations of endocrine bone diseases related to pathological glandular PTH secretion using a multi-scale bone cell population model

**Authors:** Corinna Modiz, Natalia M. Castoldi, Stefan Scheiner, Javier Martínez-Reina, Jose L. Calvo-Gallego, Vittorio Sansalone, Saulo Martelli, Peter Pivonka

PMC · DOI: 10.3389/fbioe.2025.1619276 · Frontiers in Bioengineering and Biotechnology · 2025-10-01

## TL;DR

The paper introduces a new computational model to simulate bone diseases caused by abnormal parathyroid hormone secretion, offering insights into disease progression and treatment.

## Contribution

A novel semi-coupled model integrating pulsatile PTH secretion with bone cell dynamics, enabling realistic simulation of endocrine bone diseases.

## Key findings

- The model successfully reproduces catabolic bone diseases with realistic bone volume fraction changes over a year.
- Conventional models fail to capture diseases with altered PTH pulse characteristics, but the semi-coupled approach succeeds.
- The approach provides a more physiologically accurate framework for studying endocrine bone disorders.

## Abstract

Bone diseases significantly impact global health by compromising skeletal integrity and quality of life. In disease states linked to parathyroid hormone (PTH) glandular secretion, disrupted PTH patterns typically promote osteoclast proliferation, leading to increased bone resorption.

While mathematical modeling has proven valuable in analyzing bone remodeling, current bone cell population models oversimplify PTH secretion by assuming constant levels, limiting their ability to represent disorders characterized by variations in PTH pulse characteristics. To address this, we present a novel semi-coupled approach integrating a two-state PTH receptor model with an established bone cell population model. Instead of conventional Hill-type functions, we implement a cellular activity function derived from the receptor model, incorporating pulsatile PTH patterns, cell dynamics, and intracellular communication pathways.

Our numerical simulations demonstrate the model’s capability to reproduce various catabolic bone diseases, providing realistic changes in bone volume fraction over a 1-year period. Notably, while direct implementation of PTH disease progression in the bone cell population model fails to capture diseases only characterized by altered pulse duration and baseline, such as glucocorticoid-induced osteoporosis, our semi-coupled approach successfully models these conditions.

This physiologically more realistic approach to endocrine disease modeling offers potential implications for optimizing therapeutic interventions and understanding disease progression mechanisms.

## Linked entities

- **Proteins:** PTH (parathyroid hormone)
- **Diseases:** osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** Bone diseases (MESH:D001847), endocrine disease (MESH:D004700), osteoporosis (MESH:D010024)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12521151/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12521151/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC12521151/full.md

---
Source: https://tomesphere.com/paper/PMC12521151